Moreover, BOB1 positivity is reported in >50% of RSCs, whereas OCT2 expression may occur less frequently; co-expression of both BOB1 and OCT2 in cHL is extremely rare, unlike in DLBCL RSCLs [5] (Supplementary Table S2). The gene discussed is POU2AF1; the disease is diffuse large B-cell lymphoma.